NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NA
Post# of 31
(Total Views: 186)
Posted On: 07/12/2019 5:42:24 PM
NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently reported the completion of its purchase of a 49% interest in Cannova Medical Ltd. The company also holds the option to acquire the remaining 51% interest in Cannova. A recent article discussing the company reads, “Cannova Medical is a provider of innovative solutions for cannabis consumption. Pursuing its interest in investment across all vertically integrated aspects of the cannabis sector, with a focus on strategic revenue generation, Nabis selected Cannova because of its innovative take on consumable cannabis. In connection with this transaction, Nabis will have exclusive distribution rights in North America. . . . Cannova, based in Israel, is developing an alternative method for cannabis consumption in the form of a sublingual strip. The sublingual strips are infused with cannabis molecules that are produced using a patent-protected process involving the combination of various formulations with water-soluble cannabinoids and natural active ingredients. The sublingual strip allows producers to more effectively control dosage quantities and significantly increases the effect of the cannabis, allowing it to be used for a variety of purposes, including pain management, as a concentration aid, as an antidepressant and to support better sleep.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently reported the completion of its purchase of a 49% interest in Cannova Medical Ltd. The company also holds the option to acquire the remaining 51% interest in Cannova. A recent article discussing the company reads, “Cannova Medical is a provider of innovative solutions for cannabis consumption. Pursuing its interest in investment across all vertically integrated aspects of the cannabis sector, with a focus on strategic revenue generation, Nabis selected Cannova because of its innovative take on consumable cannabis. In connection with this transaction, Nabis will have exclusive distribution rights in North America. . . . Cannova, based in Israel, is developing an alternative method for cannabis consumption in the form of a sublingual strip. The sublingual strips are infused with cannabis molecules that are produced using a patent-protected process involving the combination of various formulations with water-soluble cannabinoids and natural active ingredients. The sublingual strip allows producers to more effectively control dosage quantities and significantly increases the effect of the cannabis, allowing it to be used for a variety of purposes, including pain management, as a concentration aid, as an antidepressant and to support better sleep.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)